| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Roivant Sciences Ltd.'s insiders have reduced their positions by a net 4,914,489 shares worth roughly $168.8M. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
On the other side, 1 insider reduced a position over the period. ROIV sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 113.32M | $4.10B | - | |
| 10% | 34.49M | $1.25B | - | |
| Pres | 18.68M | $675.20M | - | |
| CEO | 16.74M | $605.01M | - | |
| Dir | 13.69M | $494.86M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 26, 2024 | Sukhatme Mayukh | Pres&Chief Investment Officer | Sale+OE | 886,237 | $12.01 | $10,641,738.95 | -1.5% | -13.0% | +85.3% | |
| Dec 20, 2024 | Venker Eric | President &COO | Sale+OE | 100,000 | $11.49 | $1,149,000.00 | -14.4% | -5.2% | +93.7% | |
| Dec 18, 2024 | Sukhatme Mayukh | Pres&Chief Investment Officer | Sale+OE | 412,584 | $12.05 | $4,971,637.20 | -2.1% | -8.4% | +86.4% | |
| Nov 20, 2024 | Venker Eric | President &COO | Sale+OE | 100,000 | $11.32 | $1,132,000.00 | -14.2% | -7.0% | +76.4% | |
| Oct 21, 2024 | Venker Eric | President &COO | Sale+OE | 100,000 | $11.65 | $1,165,000.00 | -13.9% | -3.0% | +53.8% | |
| Sep 26, 2024 | Qvt Financial LP74 | Director By Deputization | Sell | 926,000 | $11.82 | $10,942,820.00 | -2.0% | +3.7% | +31.1% | |
| Sep 26, 2024 | Gold Daniel Allen73 | Director | Sell | 4,426,000 | $11.71 | $51,820,727.30 | -6.9% | +3.7% | +31.1% | |
| Sep 25, 2024 | Manchester Keith S49 | Director | Sell | 503,000 | $11.66 | $5,866,308.20 | -15.8% | +2.0% | +27.1% | |
| Sep 23, 2024 | Gline Matthew | CEO | Sale+OE | 1,983,257 | $11.79 | $23,382,600.03 | -10.0% | +0.6% | +23.9% | |
| Sep 23, 2024 | Kumar Rakhi45 | Chief Accounting Officer | Sale+OE | 250,000 | $11.89 | $2,972,500.00 | -54.4% | +0.6% | +23.9% |